Award & Investment Overview
The University of Massachusetts Amherst has selected 10 research teams for its 2026-27 Institute for Applied Life Sciences (IALS) Translational Seed Awards, providing up to $100,000 per project to advance university innovations toward commercialization. The awards support startup formation, intellectual property licensing, and partnerships with external organizations.
The portfolio spans photonics, cancer vaccines, medical diagnostics, biomanufacturing, environmental technology, artificial intelligence, and social innovation. Funding comes from the Manning Innovation Program, the U.S. National Science Foundation’s Accelerating Research Translation (ART) award, and IALS. The university has not disclosed individual award amounts or the total committed funding.
The awards provide milestone-driven, non-dilutive support for technologies and other innovations that require additional development before commercial adoption. Previous recipients have secured more than $9 million in external grants and investment, with an additional $17 million contingent on future milestones.
Approach & Ecosystem Context
The IALS Translational Seed Awards are part of UMass Amherst’s broader strategy to connect academic research with commercial and societal applications. Projects are selected through a competitive review involving university, industry, and investment experts, with recipients receiving both funding and commercialization training and mentorship.
The program supports several pathways to impact, including university spinouts, out-licensing of patented or copyrighted intellectual property, and scalable partnerships with external organizations. This flexibility is particularly relevant to a portfolio that includes both conventional technology commercialization opportunities and social innovation projects.
The Manning Innovation Program, established in 2018 through philanthropic support from Paul and Diane Manning, provides an ongoing funding mechanism for translational research and startup development. The NSF ART award adds federal support for strengthening the university’s research translation capabilities.
From a Mind the GAP perspective, the program illustrates how universities can combine philanthropic, federal, and institutional resources to maintain a commercialization pipeline. The emphasis on defined translational milestones, industry-informed selection, and ongoing mentoring helps research teams address technical and market readiness gaps before seeking licensing partners or external capital.
Innovation & Technology
1. Programmable Photonic Integrated Circuits
Lead Researcher: Amir Arbabi
This project focuses on programmable photonic integrated circuits, which use light to process or transmit information within integrated chip systems. The technology has potential applications in optical communications, computing, and advanced sensing. The Translational Seed Award will support further development toward commercial applications, although the announcement does not specify the project’s technical milestones or intended initial market.
2. NanoVax Therapeutics: Smart Nanoparticle Cancer Vaccines
Lead Researcher: Prabhani Atukorale
NanoVax Therapeutics is developing engineered nanoparticle approaches for cancer vaccines. The project focuses on using nanoparticle technology to support therapeutic vaccine development, with potential applications in cancer immunotherapy. The award will advance translational development, although specific clinical targets, preclinical results, and commercialization milestones were not disclosed.
3. IntelliRes: Optical Imaging for Transplant Organ Viability
Lead Researcher: Xian Du
IntelliRes is developing intelligent large-volume optical coherence tomography (OCT) technology to assess the viability of organs intended for transplantation. The project aims to apply advanced optical imaging to organ evaluation, potentially providing additional information to support transplant-related decisions. The award will support further technology development toward clinical and commercial applications.
4. Low-Cost Basal Metabolic Rate Tracking
Lead Researchers: Jeremy Gummeson and Michael Busa
This project is developing models for tracking basal metabolic rate using low-cost, commercially available thermoelectric generators. The approach explores whether accessible sensing components can support metabolic monitoring, with potential applications in health assessment and physiological measurement. Further validation will be needed to establish measurement accuracy and practical uses.
5. CereLink-Tx: Human Cerebellar Organoids for Therapeutic Discovery
Lead Researcher: ChangHui Pak
CereLink-Tx is developing cerebellar organoids as a human cellular platform for preclinical therapeutic discovery. The project targets congenital and degenerative cerebellar diseases and aims to create a model that can support Investigational New Drug (IND) development activities. Potential commercial applications include drug discovery, preclinical testing, and therapeutic development partnerships.
6. GranoGen: Wastewater Treatment Technology
Lead Researcher: Chul Park
GranoGen is developing a granulation induction approach designed to be compatible with existing conventional wastewater treatment infrastructure. The technology aims to support improved wastewater treatment processes without requiring complete replacement of installed systems. Potential applications include municipal and industrial wastewater treatment facilities seeking practical upgrades to existing operations.
7. Rapid Host Cell Protein Detection for Bioproduction
Lead Researcher: Vincent Rotello
This project is developing a rapid method for detecting host cell proteins across different bioproduction systems using polymer fluorescence fingerprinting. Host cell proteins are impurities that can remain during biological manufacturing. The technology has potential applications in biopharmaceutical quality control, process development, and analytical testing across multiple production platforms.
8. Kunam Medical: Electric Field-Assisted Tumor Biopsy
Lead Researcher: Govind Srimathveeravalli
Kunam Medical is developing a device and process for tumor sampling using electric field-assisted biopsy. The project aims to advance a medical technology for collecting tumor tissue, with potential applications in oncology diagnostics and clinical sampling procedures. The award will support further translational development, although the announcement does not disclose clinical validation or regulatory status.
9. Ntu Co-Lab: Alternative Justice Innovation in Africa
Lead Researcher: Sindiso Mnisi Weeks
Ntu Co-Lab focuses on advancing UbuNtu’s alternative justice approaches in African contexts. The project seeks to translate research and practice into scalable models for social and community impact. Potential pathways include partnerships with justice organizations, community institutions, and other implementation partners rather than conventional technology licensing.
10. Naget: AI Agents for Information Access
Lead Researcher: Hamed Zamani
Naget is developing a customizable and adaptable ecosystem of artificial intelligence agents for information access. The project focuses on AI-enabled systems that could support how users locate and interact with information across different environments. Potential applications include enterprise information retrieval, knowledge management, and specialized AI-assisted information services.

